Abstract
Many medications have been suggested which may diminish the effects of aging on various tissues in the body. Particularly notable have been the interventions into the characteristic changes involving the skin, sensory, cardiovascular and neurologic systems, all of which have been considered to abrogate the declining intracellular metabolic maintenance. Intervention by the use of sex hormones is more definitive and serves multiple systems. The hormones have peripheral somatic action but the major known responses deal with primary and secondary sexual tissues.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Speroff, L., Glass, R.H., Kase, N.G. Clinical Gynecologic Endocrinology and Infertility. Baltimore: Williams and Wilkins Co., 1973.
Ewing, L.L. Testis: Changes with Age. In: Benign Prostatic Hyperplasia. DREW publication No. (NIH) 76 - 1113, 1976.
Ewing, L.L., Johnson, B.H., Desjardins, C., Celgg, R.F. Age and steroidogenic elements of testes. Proc. Soc. Exp. Biol. Med. 140: 907, 1972.
Ito, T., Horton, R. Dihydrotestosterone in human peripheral plasma. J. Clin. Endo. Metab. 31: 361, 1970.
Baird, D.T., Horton, R., Longcope, C., Tait, J.F. Steroid prehormones. Persp. Biol. Med. 11: 384, 1968.
Vermeulen, A., Rubens, R., Verdonck, L. Testosterone secretion and metabolism in male senescence. J. Clin. Endocr. 34: 730, 1972.
Stearns, E.L., MacDonnell, J.A., Kaufman, B.J., Padua, R. Declining testicular function with age. Am. J. Med. 57: 761, 1974.
Longcope, C., Widrich, W., Sawin, C.T. The secretion of estrone and estradiol by human testis. Steroids 20: 439, 1972.
Siiteri, P.K., Wilson, J.D. DHT in prostatic hypertrophy. J. Clin. Invest. 49: 1737, 1970.
MacDonald, P.C. Origin of Estrogen in Men. In: Benign Pro-static Hyperplasia. DHEW Publication No. (NTH) 76 - 1113, 1976.
Longcope, C. The effect of hCG on plasma steroid levels in young and old men. Steroids 21: 583, 1973.
Persky, H., OBrien, C.P., Khan, M.A. Reproductive hormone levels, sexual activity and moods during the menstrual cycle. Psychosom Med. 38: 62, 1976.
Persky, H., OBrien, C.P., Khan, M.A. Reproductive hormone levels, sexual activity and moods during the menstrual cycle. Psychosom Med. 38: 62, 1976.
Rubens, R., Dohnt, M., Vermeulen, A. Further studies in Leydig cell function in old age. J. Clin. Endocrinol. Metab. 39: 40, 1974.
Chan, L., O'Malley, B.W. Mechanism of action of the sex steroid hormones. Part 1. N. Engl. J. Med. 294: 1322, 1976.
Paolik, E.J., Coulson, P.B. Modulation of estrogen receptors in four different target tissues. J. Steroid Biochem. 7: 369, 1976.
Eskin, B.A., Hosseini, M. Intermediate steroid plasma levels in late reproductive years in women. (manuscript in preparation) 1977
Finch, C.E., Flurkey, K. The molecular biology of estrogen replacement therapy. Contemp. Ob. Gyn. 9: 97, 1977.
Sherman, B.M., Korenman, S.G. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J. Clin. Invest. 55: 699, 1975.
Horwitz, K.B., McGuire, W.L., Pearson, 0.H., Segaloff, A. Preliminary response to endocrine therapy in breast cancer. Science 189: 726, 1975.
Jensen, E.V., Suzuki, T., Kawashina, T. A two-step mechanism for the interaction of estradiol with rat uterus. Proc. Natl. Acad. Sci. USA 59: 632, 1968.
Shyamala, G., Gorski, J. Interrelationships of estrogen receptors in the nucleus and cytosol. J. Cell. Biol. 35: 125A, 1967.
Gorski, J., Williams, W., Giamopoulos, G., Stancil, G. The continuing evolution of an estrogen-receptor model. In: Receptors for Reproductive Hormones. Eds. B.W. O'Malley and A.R. Means. New York: Plenum Press, 1973.
Jensen, E.V., Mohla, S., Brecher, P.I., DeSombre, E.R. Estrogen receptor transformation and nuclear RNA synthesis. In: Receptors for Reproductive Hormones. Eds. B.W. O'Malley and A.R. Means. New York: Plenum Press, 1973.
Anderson, J.N., Peck, E.J., Clark, J.H. Estrogen-induced uterine responses and growth. Endocrin. 96: 160, 1975.
Clark, J.H., Peck, E.J., Anderson, J.N. Nafoxidine, mode of action on estrogen receptor systems. Nature 251: 446, 1974.
McGuire, W.L., Carbone, P.P., Vollmer, E.P. Estrogen Receptors in Human Breast Cancer. New York: Raven Press, 1975.
Nelson, J.F., Holinka, C.F., Finch, C.E. Loss of cytoplasmic estradiol binding capacity during aging in uteri of C57BL/6J mice. Proc. Endoc. Soc. 58: 349, 1976.
Hoover, R., Gray, L.A.Cole, P. Menopausal estrogens and breast cancer. N. Engl. J. Med. 295: 401, 1976.
MacMahon, B., Austin, J.H. Association of carcinomas of the breast and corpus uteri.Cancer 23: 275, 1969.
Lipsett M.B.use and cancer "risk. JAMA 237:1112, 1977.
Bartuska, D.G. Physiology of aging: metabolic changes during the climacteric and menopausal periods. Clin. Ob. Gyn. 20: 165, 1977.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer Science+Business Media New York
About this chapter
Cite this chapter
Eskin, B.A. (1978). Sex Hormones and Aging. In: Roberts, J., Adelman, R.C., Cristofalo, V.J. (eds) Pharmacological Intervention in the Aging Process. Advances in Experimental Medicine and Biology, vol 97. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7793-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7793-1_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7795-5
Online ISBN: 978-1-4684-7793-1
eBook Packages: Springer Book Archive